Alliance for Clinical Trials in Oncology Clinical Trials Core

/ABSTRACT – CLINICAL TRIALS DEVELOPMENT CORE The Alliance for Clinical Trials in Oncology is an experienced multi-institutional cancer clinical trials group that develops and conducts clinical trials with promising new cancer therapies by utilizing the best science to develop optimal treatment and prevention strategies for cancer, as well as research methods to alleviate side effects of cancer and cancer treatments. The Clinical Trials Core provides expertise and operational efficiency for clinical trial development and conduct for NCTN trials that the Network Group Operations Center leads. The Alliance provides a comprehensive and highly efficient clinical trials infrastructure, access to experienced collaborators across all disciplines of oncology clinical trials research, and a diverse portfolio of trials for patients with breast, gastrointestinal, genitourinary, respiratory, central nervous system, and hematological malignancies, in addition to rare tumors. Particular strengths of the Alliance include the long-standing tradition of collaborative research of the legacy members, its focus on science, innovation, and mentorship, its successful track record in developing multidisciplinary therapeutic solutions for cancer patients, its seamless incorporation of correlative science for the discovery of prognostic and predictive biomarkers, and its commitment to all patient populations. The Mission of the Alliance for Clinical Trials in Oncology is to reduce the impact of cancer by: • Delivering specialized expertise and maximizing operational efficiency to streamline the development and conduct of NCTN trials led by the Network Group Operations Center; • Conducting high-quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; • Furthering our understanding of the biological basis of the cancer process and its treatment; from discovery, to validation, to clinical practice; • Providing a scientific and operational infrastructure for innovative clinical and translational research in the academic and community settings. Project Number: 2U10CA180821-12 | Fiscal Year: 2026 | NIH Institute/Center: National Cancer Institute (NCI) | Principal Investigator: Evanthia Galanis | Institution: ALLIANCE NCTN FOUNDATION, CHICAGO, IL | Award Amount: $83,516 | Activity Code: U10 | Study Section: Special Emphasis Panel[ZRG1 CDPT-F (56)] View on NIH RePORTER: https://reporter.nih.gov/project-details/11291202